Pharma antitrust dispute ‘must be arbitrated’, says US court
A US appeals court has upheld its ruling that an antitrust class action against US pharmaceutical conglomerate Johnson & Johnson over an alleged anticompetitive scheme to protect billion-dollar sales of an autoimmune drug must be arbitrated.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10